The Challengers: Five Companies Racing to Phase 3 Behind the Lilly-Novo duopoly, five companies are building GLP-1 programs with distinct competitive angles
Combination of CTLA-4 and PD-1 blockers for treatment of cancer
Lee MS, Clarke C, Jiang Z, Manyam GC, Tian F, Lu Y, Morris J, Broom BM, Menter D, Vilar Sanchez E, Shureiqi I, Raghav KPS, Eng C, Chang GJ, Simon I, Bernards R, Mills GB, Overman MJ, Maru DM, Kopetz S
When you buy non-FDA approved drugs from unknown sources, you can never be sure whether they were made or stored in safe conditions
Many service members transition to civilian careers within 5-10 years of leaving service
(Clinical Psychology) Well versed in helping clients deal with emotional wellbeing struggles, lack of motivation, consistency challenges, addictions, work-life balance, daily life challenges and other higher order mental health conditions too